Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
The laws passed in the US Congress to limit the regulation of US banks imposed after the 2009 crisis led to leaving a gap for midsized banks where there would be less regulation. The appointment of Randy Quarles to Fed Vice Chair Supervision by Mr. Trump in 2019 led to the new culture which took the attitude the less regulation the better 14 years after the 2009 banking crisis, and the collapse of several banks in 2023, endangering the US banking system when the US needs a huge capacity to invest in the nation.
Linked Articles
The need for infrastructure spending in other parts of Russia, for R&D development and making the transition away from dependence on oil revenues, as competing needs for capital. This also happens as currency values are declining for emerging markets and it is increasingly difficult to attract foreign investment in 2014, leading to slowing growth with high inflation.
Linked Articles
Putin's Olympian Construction Zone
Wall Street Journal 11/05/2013
Putin’s Olympic Fever DreamNew York Times 01/22/2014
No more moonshot projects, say CEO McInerney, and Ray Conner, head of the airplanes division. The cost of the Dreamliner exceeds $50 billion by 2015, according to Barclays Capital, including R&D and related costs. The focus is now on incremental change, on striving for simplicity, reducing complexity, and increasing reliability, after the experience of over 3 years of repeated delays, cost overruns, and reliability failures, high complexity, and overloaded manufacturing processes on the Dreamliner project.
Linked Articles
At Boeing, Innovation Means Small Steps, Not Giant Leaps
Wall Street Journal 04/03/2015
Boeing Hits a MilestoneWall Street Journal 06/08/2012
Without a new approach to increasing health care costs, especially considering the demographic changes in the U.S. with more people on Medicare in future years, the problems of defunding other areas such as education, R&D, and infrastructure, to fund these increases is likely to continue. Estimates show that the 50 million Americans enrolled in Medicare in 2012 will grow to 80 million by 2030, according to the Medicare program actuaries. Demographic changes as the baby boom generation ages mean more Americans relying on Medicare and Medicaid. With continually increasing health care costs from costly technologies, increasing of diabetes, asthma and other diseases, pricing in the medical industry, and some fraud costs, this is a toxic mix that will lead to to a situation where one of three dollars in spending get swallowed up here.
Linked Articles
Beneath Budget Battle, a Health-Spending Juggernaut
Wall Street Journal 12/17/2012
What to Do on the Day After ObamaCareWall Street Journal 04/03/2012
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Linked Articles
Midterm Elections 2014: Rand Paul Is Go-To Republican for 2014 Candidates
Wall Street Journal 11/05/2014
Rand Paul: No ‘Great Compromiser’Wall Street Journal 02/02/2011
Working with smaller R&D budgets and focussing the research on a few areas, collaboration with universities, and other ways to get more out of the R&D dollar.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Novartis: Radically Remaking Its Drug BusinessBusinessWeek 06/11/2009
Linked Articles
Siemens Chief Meets Putin in Russia
Wall Street Journal 03/27/2014
Exxon Says Russian Projects Remain on TrackWall Street Journal 03/06/2014
A focus on pure R&D and not building new products hurt Nokia badly.
Linked Articles
Nokia Slips to Seventh in Smartphone Market
Wall Street Journal 11/15/2012
Nokia's Bad Call on SmartphonesWall Street Journal 07/18/2012
A way out of conflict, wasted resources, and misshaped priorities, through a strong push for expanded trade and a free trade agreement between India and Pakistan. After several generations of conflict a way out. An opportunity to do in South Asia what happened between France and Germany under Adenauer, Monnet and De Gaulle. The Shaikh-Boskin proposal calls for expanded trade between India and Pakistan, and a free trade agreement between the two neighbors similiar to NAFTA in North America, and the European Common Market in Europe. This would generate a surge in growth in South Asia similiar to what happened in China in the last two decades and create new opportunities for hundreds of millions of people in South Asia.
Linked Articles
Pakistan's Untold Economic Story
Wall Street Journal 04/24/2012
A Passage to India-Pakistan PeaceWall Street Journal 04/16/2012
Israel's Teva Pharmaceutical is the world's largest maker of generic drugs, followed by Watson Pharmaceuticals and Novarti's Sandoz unit.
Linked Articles
Wall Street Journal 05/08/2012
Former Test-Tube Washer Built Generic-Drug Maker TevaWall Street Journal 11/23/2011
The Autonomy acquisition charge of $8.8 billion announced by CEO Meg Whitman on Nov. 20, 2012, come at a time of declining sales and margins in its printer and PC businesses. The costly charges on bad acquisitions by H-P is likely to hurt investment in R&D for years.
Linked Articles
Hewlett's Loss: A Folly Unfolds By the Numbers
New York Times 11/20/2012
Chief Reboots H-P After ScandalWall Street Journal 02/18/2011
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Glaxo Tries Biotech Model to Spur Drug InnovationsWall Street Journal 07/01/2010
Can the long standing independent operation of Genentech's discovery team under Levinson be maintained under the effort to integrate Genetech more into Roche. Will it result in synergies removing "a Chinese wall" as a head of Roche R&D puts it or will it lead to the loss of key members of the team over time especially as they were not brought into the discussion process about this move leaving them in confusion.
Linked Articles
Roche's Big Hurdle with Genentech
BusinessWeek 07/24/2008
Roche Bid Blindsided GenentechWall Street Journal 07/22/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1